Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Brandon M. Lehrich, Khodayar Goshtasbi, Arash Abiri, Tyler M. Yasaka, Peter Papagiannopoulos, Bobby A. Tajudeen, Elizabeth A. Brem & Edward C. Kuan. (2021) Treatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma. Leukemia & Lymphoma 62:3, pages 727-730.
Read now
Read now
Qixiang Rong, Yan Gao, Qichun Cai, Xiaoxiao Wang, Bing Bai, Liqin Ping, Haixia He, Huilan Rao, Yujing Zhang, Zhiming Li, Qingqing Cai, Wenqi Jiang & Huiqiang Huang. (2021) High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). Expert Review of Anticancer Therapy 21:1, pages 121-127.
Read now
Read now
Paola Ghione, Shunan Qi, Brandon S. Imber, Venkatraman Seshan, Alison Moskowitz, Natasha Galasso, Matthew Lunning, David Straus, Craig Sauter, Parastoo Dahi, Ahmet Dogan, Joachim Yahalom & Steven Horwitz. (2020) Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population. Leukemia & Lymphoma 61:14, pages 3331-3341.
Read now
Read now
Articles from other publishers (28)
Yu‐Ce Wei, Fei Qi, Bao‐Min Zheng, Chang‐Gong Zhang, Yan Xie, Bo Chen, Wei‐Xin Liu, Wei‐Ping Liu, Hui Fang, Shu‐Nan Qi, Di Zhang, Yue Chai, Ye‐Xiong Li, Wei‐Hu Wang, Yu‐Qin Song, Jun Zhu & Mei Dong. (2023)
Intensive therapy can improve long‐term survival in newly diagnosed, advanced‐stage extranodal
NK
/T‐cell lymphoma: A multi‐institutional, real‐world study
. International Journal of Cancer.
Crossref
Crossref
Jing Tian, Miaowang Hao, Qiang Liu, Fang Xiao, Yuanchun Li, Meiying Qi, Jing Gao, Li Liu & Dandan Yin. (2022) Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective study. Hematological Oncology 41:3, pages 396-406.
Crossref
Crossref
Jia‐Xin Liu, Xin Liu, Yong Yang, Wei‐Ping Liu, Ying Wang, Xia He, Li‐Ling Zhang, Bao‐Lin Qu, Li‐Ting Qian, Xiao‐Rong Hou, Xue‐Ying Qiao, Hua Wang, Gao‐Feng Li, Yuan Zhu, Jian‐Zhong Cao, Jun‐Xin Wu, Tao Wu, Su‐Yu Zhu, Mei Shi, Hui‐Lai Zhang, Hang Su, Yu‐Jing Zhang, Jun Zhu, Shu‐Nan Qi, Ye‐Xiong Li & Yu‐Qin Song. (2023) Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T‐cell lymphoma. Cancer Reports 6:5.
Crossref
Crossref
Xiaohua He, Yan Gao, Zhiming Li & Huiqiang Huang. (2021) Review on natural killer/T‐cell lymphoma. Hematological Oncology 41:2, pages 221-229.
Crossref
Crossref
Qiang Zeng, Hang Zhang, Pu Kuang, Jian Li, Xinchuan Chen, Tian Dong, Qiuhui Wu, Chuanli Zhang, Chunping Chen, Ting Niu, Ting Liu, Zhigang Liu & Jie Ji. (2023) A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma. Frontiers in Oncology 13.
Crossref
Crossref
Eric Tse, Christopher P. Fox, Alexander Glover, Sang Eun Yoon, Won Seog Kim & Yok-Lam Kwong. (2022) Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management. Seminars in Hematology 59:4, pages 198-209.
Crossref
Crossref
Tuğrul Elverdi, Mustafa Furkan Hıyamlı, Betül Şahin & Ahmet Emre Eşkazan. (2022)
A new dawn for upfront autologous
SCT
in
NK
/T‐cell lymphomas: One more step forward in reasoning
. International Journal of Cancer 151:5, pages 661-664.
Crossref
Crossref
Chuanxu Liu, Hao Ding, Qi Zhu, Peng Liu, Yang Zhu, Lifeng Wang, Yujie Ma, Wenhao Zhang, Shu Tian, Xiaoyan Zhang, Lina Jin, Ligen Liu, Zhichao Li, Siguo Hao & Rong Tao. (2022)
Induction with
MEDA
regimen and consolidation with
Auto‐HSCT
for stage
IV NKTCL
patients: A prospective multicenter study
. International Journal of Cancer 151:5, pages 752-763.
Crossref
Crossref
John C. Reneau, Polina Shindiapina, Zachary Braunstein, Youssef Youssef, Miguel Ruiz, Saira Farid, Walter Hanel & Jonathan E. Brammer. (2022) Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions. Journal of Clinical Medicine 11:10, pages 2699.
Crossref
Crossref
Khodr Terro, Layal Sharrouf & Jean El Cheikh. (2022) Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma. Frontiers in Oncology 12.
Crossref
Crossref
Christopher P. Fox, Matthew J. Ahearne, Ruth Pettengell, Claire Dearden, Dima El‐Sharkawi, Shireen Kassam, Lucy Cook, Kate Cwynarski, Tim Illidge & Graham Collins. (2021) Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline. British Journal of Haematology 196:3, pages 507-522.
Crossref
Crossref
Jie Ji, Zhigang Liu, Pu Kuang, Tian Dong, Xinchuan Chen, Jian Li, Chuanli Zhang, Jiazhuo Liu, Li Zhang, Kai Shen & Ting Liu. (2021)
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high‐risk or relapsed/refractory
non‐Hodgkin
's lymphomas
. International Journal of Cancer 149:12, pages 2075-2082.
Crossref
Crossref
Hua Wang, Bi-bo Fu, Robert Peter Gale & Yang Liang. (2021) NK-/T-cell lymphomas. Leukemia 35:9, pages 2460-2468.
Crossref
Crossref
Na Li, Ming Jiang, Wan-Chun Wu, Wen-Wen Wei & Li-Qun Zou. (2021) How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome. Frontiers in Oncology 11.
Crossref
Crossref
Yang Liang Boo & Liang Piu Koh. (2021) Hematopoietic Stem Cell Transplantation in T Cell and Natural Killer Cell Lymphomas: Update on Recent Advances. Transplantation and Cellular Therapy 27:7, pages 571-588.
Crossref
Crossref
Laure Philippe Walter, Lucile Couronné, Jean‐Philippe Jais, Phong‐Dinh Nguyen, Didier Blaise, Arnaud Pigneux, Gérard Socié, Catherine Thieblemont, Emmanuel Bachy, Nathalie Fegueux, Patrice Chevallier, Mohamad Mohty, Ibrahim Yakoub‐Agha, Regis Peffault de Latour, Arnaud Jaccard & Olivier Hermine. (2021)
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/
T‐Cell
lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (
SFGM‐TC
)
. American Journal of Hematology 96:7, pages 834-845.
Crossref
Crossref
Ga-Young Song, Dok Hyun Yoon, Cheolwon Suh, Joon Ho Moon, Dong Won Baek, Jin Seok Kim, Gyeong-Won Lee, Jun Ho Yi, Yong Park, Ki Sun Jung, Seok Jin Kim, Deok-Hwan Yang & Won Seog Kim. (2020) Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma. Bone Marrow Transplantation 56:5, pages 1205-1208.
Crossref
Crossref
Jaap A. van Doesum, Anne G. H. Niezink, Gerwin A. Huls, Max Beijert, Arjan DiepstraTom van Meerten. (2021) Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment. HemaSphere 5:2, pages e523.
Crossref
Crossref
Seong Hyun Jeong. (2020) Extranodal NK/T cell lymphoma. BLOOD RESEARCH 55:S1, pages S63-S71.
Crossref
Crossref
Pamela B. Allen & Mary Jo Lechowicz. (2019) Management of NK/T-Cell Lymphoma, Nasal Type. Journal of Oncology Practice 15:10, pages 513-520.
Crossref
Crossref
Allyson Flower, Ana C. Xavier & Mitchell S. Cairo. (2019)
Mature (non‐anaplastic, non‐cutaneous) T‐/
NK
‐cell lymphomas in children, adolescents and young adults: state of the science
. British Journal of Haematology 185:3, pages 418-435.
Crossref
Crossref
Motoko Yamaguchi, Masahiko Oguchi & Ritsuro Suzuki. (2018) Extranodal NK/T-cell lymphoma: Updates in biology and management strategies. Best Practice & Research Clinical Haematology 31:3, pages 315-321.
Crossref
Crossref
Motoko Yamaguchi, Ritsuro Suzuki & Masahiko Oguchi. (2018) Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type. Blood 131:23, pages 2528-2540.
Crossref
Crossref
Jingwen Wang, Liqiang Wei, Jin Ye, Lei Yang, Xin Li, Jia Cong, Na Yao, Xueying Cui, Yiping Wu, Jing Ding & Le Zhang. (2017) Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center. International Journal of Hematology 107:1, pages 98-104.
Crossref
Crossref
Xiaotian Wang, Zimu Gong, Shawn Xiang Li, Wei Yan & Yongsheng Song. (2017) Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature. BMC Urology 17:1.
Crossref
Crossref
Helen Ma & Maher Abdul-Hay. (2016) T-cell lymphomas, a challenging disease: types, treatments, and future. International Journal of Clinical Oncology 22:1, pages 18-51.
Crossref
Crossref
Bradley M. Haverkos, Zenggang Pan, Alejandro A. Gru, Aharon G. Freud, Rachel Rabinovitch, Meng Xu-Welliver, Brad Otto, Carlos Barrionuevo, Robert A. Baiocchi, Rosemary Rochford & Pierluigi Porcu. (2016) Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases. Current Hematologic Malignancy Reports 11:6, pages 514-527.
Crossref
Crossref
S H Lim, S H Hyun, H S Kim, J Y Lee, K H Yoo, K S Jung, H-N Song, J Cho, S Park, Y H Ko, S J Kim, J Y Choi & W S Kim. (2016) Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL. Bone Marrow Transplantation 51:6, pages 807-812.
Crossref
Crossref